PT94731A - Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas - Google Patents

Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas

Info

Publication number
PT94731A
PT94731A PT94731A PT9473190A PT94731A PT 94731 A PT94731 A PT 94731A PT 94731 A PT94731 A PT 94731A PT 9473190 A PT9473190 A PT 9473190A PT 94731 A PT94731 A PT 94731A
Authority
PT
Portugal
Prior art keywords
pyrimidine
intermediaries
nucleoside
animal
pharmaceutical compositions
Prior art date
Application number
PT94731A
Other languages
English (en)
Other versions
PT94731B (pt
Inventor
Richard Walter
Paul Coe
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898916323A external-priority patent/GB8916323D0/en
Priority claimed from GB898922393A external-priority patent/GB8922393D0/en
Application filed by Univ Birmingham filed Critical Univ Birmingham
Publication of PT94731A publication Critical patent/PT94731A/pt
Publication of PT94731B publication Critical patent/PT94731B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT94731A 1989-07-17 1990-07-17 Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas PT94731B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898916323A GB8916323D0 (en) 1989-07-17 1989-07-17 Nucleosides
GB898922393A GB8922393D0 (en) 1989-10-04 1989-10-04 Antiviral pyrimidines

Publications (2)

Publication Number Publication Date
PT94731A true PT94731A (pt) 1991-03-20
PT94731B PT94731B (pt) 1997-04-30

Family

ID=26295621

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94731A PT94731B (pt) 1989-07-17 1990-07-17 Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas

Country Status (19)

Country Link
US (1) US5356882A (pt)
EP (1) EP0409575A1 (pt)
JP (1) JP2502813B2 (pt)
KR (1) KR927003616A (pt)
AT (1) ATE161267T1 (pt)
AU (3) AU648746B2 (pt)
CA (1) CA2065279A1 (pt)
FI (1) FI920197A0 (pt)
HU (1) HUT59694A (pt)
IE (1) IE902574A1 (pt)
IL (1) IL95103A (pt)
LV (1) LV10104B (pt)
MX (1) MX9203668A (pt)
MY (1) MY105944A (pt)
NO (1) NO178930C (pt)
NZ (1) NZ234534A (pt)
PL (1) PL167317B1 (pt)
PT (1) PT94731B (pt)
WO (1) WO1991001326A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270315A (en) * 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US7119202B1 (en) 1989-02-08 2006-10-10 Glaxo Wellcome Inc. Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
US6903224B2 (en) 1988-04-11 2005-06-07 Biochem Pharma Inc. Substituted 1,3-oxathiolanes
US6350753B1 (en) 1988-04-11 2002-02-26 Biochem Pharma Inc. 2-Substituted-4-substituted-1,3-dioxolanes and use thereof
UA45942A (uk) * 1989-02-08 2002-05-15 Біокем Фарма, Інк. 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
US5643913A (en) * 1990-07-19 1997-07-01 Glaxo Wellcome Inc. Pharmaceutical compositions of 5-substituted uracil compounds
ES2111569T3 (es) 1990-07-19 1998-03-16 Wellcome Found Inactivadores de enzimas.
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US6228860B1 (en) 1990-11-13 2001-05-08 Biochem Pharma Inc. Substituted 1,3-oxathiolanes with antiviral properties
US6369066B1 (en) 1990-11-13 2002-04-09 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DE4110977A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB9109186D0 (en) * 1991-04-29 1991-06-19 Wellcome Found Preparation of thionucleosides
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
WO1994001117A1 (en) * 1992-07-02 1994-01-20 The Wellcome Foundation Limited Therapeutic nucleosides
WO1994001443A1 (en) * 1992-07-02 1994-01-20 The Wellcome Foundation Limited Therapeutic nucleosides
GB9218810D0 (en) * 1992-09-04 1992-10-21 Univ Birmingham Antiviral pyrimidine nucleosides
AU4125099A (en) * 1998-06-01 1999-12-20 S & T Science And Technology Inc. Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
KR20000008131A (ko) * 1998-07-10 2000-02-07 정낙신 치오뉴클레오시드 유도체 및 그들의 제조방법
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
EP1387850A2 (en) 2001-05-18 2004-02-11 Rakesh Kumar Antiviral nucleosides
AU2002360697B2 (en) * 2001-12-20 2009-04-23 Beth Israel Deaconess Medical Center Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
EP1541581A1 (en) * 2002-08-22 2005-06-15 Geneticlab Co., Ltd. 4 -thionucleotide
CA2698645A1 (en) * 2007-09-10 2009-03-19 Eiichi Kodama Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
DE3102136A1 (de) * 1981-01-23 1982-08-19 Bayer Ag, 5090 Leverkusen Neue verbindung bay i 3265 komponente a, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3236389A1 (de) * 1982-10-01 1984-04-05 Bayer Ag, 5090 Leverkusen Neue nucleosidverbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
EP0516186A3 (en) * 1987-04-16 1993-01-13 Medivir Aktiebolag Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
JP3207852B2 (ja) * 1989-09-15 2001-09-10 サザン リサーチ インスティテュート 抗ウィルス剤及び抗癌剤としての２′―デオキシ―４′―チオリボヌクレオシド
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides
US5128458A (en) * 1990-04-20 1992-07-07 Southern Research Institute 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
DE4021006A1 (de) * 1990-07-02 1992-01-09 Hoechst Ag Pyrimidin-derivate, deren herstellung und verwendung sowie diese enthaltende arzneimittel
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.

Also Published As

Publication number Publication date
HU9200143D0 (en) 1992-04-28
PL286088A1 (en) 1991-11-04
AU5635394A (en) 1994-05-05
NO178930C (no) 1996-07-03
EP0409575A1 (en) 1991-01-23
KR927003616A (ko) 1992-12-18
AU5963490A (en) 1991-02-22
IL95103A (en) 1996-03-31
LV10104A (lv) 1994-05-10
IL95103A0 (en) 1991-06-10
NO920210L (no) 1992-01-16
ATE161267T1 (de) 1998-01-15
WO1991001326A1 (en) 1991-02-07
IE902574A1 (en) 1991-02-27
HUT59694A (en) 1992-06-29
NO920210D0 (no) 1992-01-16
MX9203668A (es) 1992-09-01
AU5635294A (en) 1994-05-19
AU668270B2 (en) 1996-04-26
CA2065279A1 (en) 1991-01-18
MY105944A (en) 1995-02-28
NO178930B (no) 1996-03-25
LV10104B (en) 1995-08-20
AU648746B2 (en) 1994-05-05
JP2502813B2 (ja) 1996-05-29
JPH04506661A (ja) 1992-11-19
US5356882A (en) 1994-10-18
AU669040B2 (en) 1996-05-23
NZ234534A (en) 1994-12-22
PL167317B1 (pl) 1995-08-31
FI920197A0 (fi) 1992-01-16
PT94731B (pt) 1997-04-30

Similar Documents

Publication Publication Date Title
PT94731A (pt) Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas
PT99545A (pt) Processo de preparacao de compostos inibidores da protease retroviral dos seus intermediarios e de composicoes farmaceuticas que os contem
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
PT95510A (pt) Processo de preparacao de pirimidina 4'-tionucleosidos e de composicoes farmaceuticas que os contem
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
PT96916A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
MA21902A1 (fr) Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant .
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
PT99756A (pt) Processo para a preparacao de 2-aril-5-(trifluorometil)pirroles uteis como agentes pesticidas e como intermediarios para a preparacao dos referidos agentes
NO902136D0 (no) Antirhinovirale (tio)morfolinyl- og piperazinyl-alkylfenoletre.
DE69019404T2 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
ES2106058T3 (es) Derivados de benzamida.
PT94036A (pt) Processo para a preparacao de piridazinaminas anti-rinovirais
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69012845T2 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze.
BR9005673A (pt) Composicao microbiocida e processo para preparar um composto de benzoxazolonas

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901018

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980731